Atossa Therapeutics, Inc. (ATOS)
4.72
+0.22
(+4.89%)
USD |
NASDAQ |
Mar 03, 16:00
4.70
-0.02
(-0.42%)
After-Hours: 20:00
Atossa Therapeutics Free Cash Flow : -26.29M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Celldex Therapeutics, Inc. | -213.66M |
| Plus Therapeutics, Inc. | -15.78M |
| Abeona Therapeutics, Inc. | -82.36M |
| Cell Source, Inc. | -- |
| Kiora Pharmaceuticals, Inc. | -10.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.005M |
| Cash from Investing (Quarterly) | -0.007M |
| Free Cash Flow Per Share (Quarterly) | -0.6981 |
| Free Cash Flow to Equity (Quarterly) | -6.012M |
| Free Cash Flow to Firm (Quarterly) | -6.012M |
| Free Cash Flow Yield | -14.39% |